Biogen Ma Inc. V. Emd Serono
SEC Filing - Biogen | Investor Relations
EMD Serono. MAYZENT (siponimod), Novartis AG. OCREVUS (ocrelizumab) ... MA Inc. and Eisai Co., LTD. 10.46+. First Amendment to Amended and Restated ...
Biogen Patent Litigation - News - Merck KGaA
In the United States Merck KGaA's subsidiary EMD Serono, Inc. (Merck) is involved in a US patent dispute with Biogen Inc., United States (Biogen) ...
SEC Filing - Biogen | Investor Relations
EMD Serono. MAYZENT (siponimod), Novartis AG. OCREVUS (ocrelizumab) ... MA Inc. and Eisai Co., LTD. Filed as Exhibit 10.45 to our Annual Report on ...
SEC Filing - Biogen | Investor Relations
EMD Serono. MAYZENT (siponimod), Novartis AG. OCREVUS (ocrelizumab), Genentech ... Vounatsos spent 20 years at Merck & Co., Inc. (Merck), a pharmaceutical ...
EMD Serono. MAYZENT (siponimod). Novartis AG. OCREVUS (ocrelizumab). Genentech. REBIF. (interferon-beta-1). EMD Serono. ZEPOSIA (ozanimod). BMS.
In May 2010 Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed ... EMD Serono, Inc. (EMD Serono) (manufacturer, marketer and seller of ...
In May 2010 Biogen MA Inc. ... (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc.
In May 2010 Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed ... of EXTAVIA), EMD Serono, Inc. (EMD Serono) (manufacturer, marketer ...